Platelet transfusions in heparin-induced thrombocytopenia: A report of four cases and review of the literature

Transfusion

Volumn 48, Issue 10, 2008, Pages 2128-2132

  Hopkins, Courtney K ^a,b   Goldfinger, Dennis ^b  

^a Box 951732 ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CASE REPORT; CLINICAL ASSESSMENT; DRUG WITHDRAWAL; FEMALE; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; LABORATORY TEST; MALE; OUTCOME ASSESSMENT; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; RETROSPECTIVE STUDY; SEROTONIN RELEASE; THROMBOCYTE TRANSFUSION; THROMBOCYTOPHERESIS; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

AGED, 80 AND OVER; ANTICOAGULANTS; FEMALE; HEPARIN; HUMANS; MALE; MIDDLE AGED; PLATELET TRANSFUSION; THROMBOCYTOPENIA;

EID: 52949118429     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2008.01822.x     Document Type: Article

References (39)

1. Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, Kelton JG. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995 332 : 1330 5.
2. Girolami B, Prandoni P, Stefani PM, Tanduo C, Sabbion P, Eichler P, Ramon R, Baggio G, Fabris F, Girolami A. The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study. Blood 2003 101 : 2955 9.
3. Francis J. Detection and significance of heparin-platelet factor 4 antibodies. Semin Hematol 2005 42 : S9 14.
4. Warkentin TE, Sheppard JA, Moore JC, Moore KM, Sigouin CS, Kelton JG. Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: how much class do we need? J Lab Clin Med 2005 146 : 341 6.
5. Amiral J, Bridey F, Dreyfus M, Vissoc AM, Fressinaud E, Wolf M, Meyer D. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost 1992 68 : 95 6.
6. Lindoff-Last E, Gerdsen F, Ackermann H, Bauersachs R. Determination of heparin-platelet factor 4-IgG antibodies improves diagnosis of heparin-induced thrombocytopenia. Br J Haematol 2001 113 : 886 90.
7. Aster RH. Heparin-independent activation of platelets by HIT antibodies: a clue to the etiology of delayed thrombocytopenia/thrombosis in patients given heparin? J Thromb Haemost 2005 3 : 2166 7.
8. Kelton JG. The pathophysiology of heparin-induced thrombocytopenia: biological basis for treatment. Chest 2005 127 : 9 20S.
9. Jang IK, Hursting MJ. When heparins promote thrombosis: review of heparin-induced thrombocytopenia. Circ 2005 111 : 2671 83.
10. Visentin J, Ford S, Scott J, Aster R. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest 1994 93 : 81 8.
11. Rauova L, Zhai L, Kowalska MA, Arepally GM, Cines DB, Poncz M. Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications. Blood 2006 107 : 2346 53.
12. Martel N, Lee J, Wells PS. Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis. Blood 2005 106 : 2710 5.
13. Warkentin TE. Heparin-induced thrombocytopenia: a ten-year retrospective. Annu Rev Med 1999 50 : 129 47.
14. Andreescu AC, Possidente C, Hsieh M, Cushman M. Evaluation of a pharmacy-based surveillance program for heparin-induced thrombocytopenia. Pharmcotherapy 2002 20 : 974 80.
15. Ahmed I, Majeed A, Powell R. Heparin-induced thrombocytopenia: diagnosis and management update. Postgrad Med J 2007 83 : 575 82.
16. Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia and cardiac surgery. Ann Thorac Surg 2003 76 : 638 48.
17. Warkentin TE, Sheppard JA, Horsewood P, Simpson PJ, Moore JC, Kelton JG. Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood 2000 96 : 1703 8.
18. Francis JL, Palmer GJ, Moroose R, Drexler A. Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery. Ann Thorac Surg 2003 75 : 17 22.
19. Arepally GM, Ortel TL. Clinical practice. Heparin-induced thrombocytopenia. N Engl J Med 2006 355 : 809 17.
20. Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinacher A. Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost 2006 4 : 759 65.
21. Lo G, Warkentin TE. Preliminary evaluation of a clinical scoring system for estimating the pre-test probability of heparin-induced thrombocytopenia: the "4 T's Blood 2003 104 : 535a.
22. Warkentin TE, Aird WC, Rand JH. Platelet-endothelial interactions: sepsis, HIT, and antiphospholipid syndrome. Hematology Am Soc Hematol Educ Prog 2003 : 497 519.
23. Pouplard C, Amiral J, Borg JY, Laporte-Simitsidis S, Delahousse B, Gruel Y. Decision analysis for use of platelet aggregation test, carbon 14 serotonin release assay, and heparin-platelet factor 4 enzyme-linked immunosorbent assay for diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol 1999 111 : 700 6.
24. Poulard C, Gueret P, Fouassier M, Ternisien C, Trossaert M, Regina S, Gruel Y. Prospective evaluation of the "4Ts" score and particle gel immunoassay specific to heparin/PF4 for the diagnosis of heparin-induced thrombocytopenia. J Thromb Haemost 2007 5 : 1373 79.
25. Shaheed G, Malkovska V, Mendoza J, Patel M, Rees J, Wesley R, Merryman P, Horne M. PF4 Enhanced assay for the diagnosis of heparin-induced thrombocytopenia in complex medical and surgical patients. Crit Care Med 2007 35 : 1691 5.
26. Look KA, Sahud M, Flaherty S, Zehnder JL. Heparin-induced platelet aggregation vs platelet factor 4 enzyme-linked immunosorbent assay in the diagnosis of heparin-induced thrombocytopenia-thrombosis. Am J Clin Pathol 1997 108 : 78 82.
27. Sheridan D, Carter C, Kelton JG. A diagnostic test for heparin-induced thrombocytopenia. Blood 1986 67 : 27 30.
28. Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004 126 : 311 337S.
29. Baroletti SA, Goldhaber SZ. Heparin-induced thrombocytopenia. Circulation 2006 114 : e355 6.
30. Kuitunen A, Suojaranta-Ylinen R, Raivio P, Kukkonen S, Lassila R. Heparin-induced thrombocytopenia following cardiac surgery is associated with poor outcome. J Cardiothorac Vasc Anesth 2007 21 : 18 22.
31. Contreras M. The appropriate use of platelets: an update from the Edinburgh Consensus Conference. Br J Haematol 1998 101 : 10 2.
32. Keeling D, Davidson S, Watson H. The management of heparin-induced thrombocytopenia. Br J Haematol 2006 133 : 259 69.
33. British Committee for Standards in Haematology, Blood Transfusion Task Force (Chairman P. Kelsey). Guidelines for the use of platelet transfusions. Br J Haematol 2003 122 : 10 23.
34. Andreescu AC, Cushman M. Case studies in heparin-induced thrombocytopenia. J Thromb Thrombolysis 2000 10 : 71 6.
35. Gettings EM, Brush KA, Van Cott EM, Hurford WE. Outcome of postoperative critically ill patients with heparin-induced thrombocytopenia: an observational retrospective case-control study. Crit Care 2006 10 : R161.
36. Drews RE. Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients. Clin Chest Med 2003 24 : 607 22.
37. Fondu P. Heparin-associated thrombocytopenia: an update. Acta Clin Belg 1995 50 : 343 57.
38. Babcock RB, Dumper CW, Scharfman WB. Heparin-induced immune thrombocytopenia. N Engl J Med 1976 295 : 237 41.
39. Cimo PL, Moake JL, Weinger RS, Ben-Menachem YB, Khalil KG. Heparin-induced thrombocytopenia: association with a platelet aggregating factor and arterial thromboses. Am J Hematol 1979 61 : 125 33.